Skip to main content

Advertisement

Log in

Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™)

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

To report a case of overlapping choriocapillaritis that initially presented as multifocal choroiditis (MFC) but later showed features compatible with acute zonal occult outer retinopathy (AZOOR) resistant to standard immunosuppression that responded only to adalimumad therapy. A 41-year-old patient presented with multiple small, discrete yellow-whitish spots in both eyes, compatible with MFC. A few weeks later, despite treatment with sub-Tenon and systemic corticosteroids, a choroidal neovascularization occurred in the right eye. The patient was treated with intravitreal anti-vascular endothelial growth factor. After 2 months, reduced visual acuity, photopsia and visual field defect in the left eye occurred. Spectral domain optical coherence tomography revealed photoreceptor outer segment defects common to all choriocapillaritis. The additional finding of an annular scotoma and a 360° ring on indocyanine green angiography led us to make the diagnosis of presumed AZOOR. Despite the combination of several immunosuppressive agents leading to temporary control of the disease, the patient experienced a further worsening. At that point, adalimumab was introduced, which led to an obvious improvement. This case supports the hypothesis that two different entities of the so-called AZOOR complex can be possible in the same eye, even asynchronously. In our case, anti-tumor necrosis factor alpha monoclonal antibody therapy represented a valid treatment option in a patient unresponsive to traditional immunosuppressive treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Nozik RA, Dorsch W (1973) A new chorioretinopathy associated with anterior uveitis. Am J Ophthalmol 76(5):758–762

    CAS  PubMed  Google Scholar 

  2. Quillen DA, Davis JB, Gottlieb JL et al (2004) The white dot syndromes. Am J Ophthalmol 137(3):538–550

    Article  PubMed  Google Scholar 

  3. Buerk BM, Rabb MF, Jampol LM (2005) Peripapillary subretinal fibrosis: a characteristic finding of multifocal choroiditis and panuveitis. Retina 25(2):228–229

    Article  PubMed  Google Scholar 

  4. Schenck F, Boke W (1990) Retinal vasculitis with multifocal retinochoroiditis. Int Ophthalmol 14(5–6):401–404

    Article  CAS  PubMed  Google Scholar 

  5. Krill AE, Archer D (1970) Choroidal neovascularization in multifocal (presumed histoplasmin) choroiditis. Arch Ophthalmol 84(5):595–604

    Article  CAS  PubMed  Google Scholar 

  6. Herbort CP, Papadia M, Neri P (2011) Myopia and inflammation. J Ophthalmic Vis Res 6:334–337

    PubMed Central  PubMed  Google Scholar 

  7. Sandrine AZ, Esther K, Bailey Freund K (2011) Simultaneous presentation of multifocal choroiditis and acute zonal occult outer retinopathy in one eye. Br J Ophthalmol 95(2):288 297–8

    Article  Google Scholar 

  8. Monson DM, Smith JS (2011) Acute zonal occult outer retinopathy. Surv Ophthalmol 156(1):23–35

    Article  Google Scholar 

  9. Gass JD (2003) Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases? Am J Ophthalmol 135(3):380–381

    Article  PubMed  Google Scholar 

  10. Gass JD (2000) The acute zonal outer retinopathies. Am J Ophthalmol 130(5):655–657

    Article  CAS  PubMed  Google Scholar 

  11. Gass JD (1993) Acute zonal occult outer retinopathy. J Clin Neuroophthalmol 13:79–97

    CAS  PubMed  Google Scholar 

  12. Gass JD (2003) Acute zonal occult outer retinopathy: Donders Lecture: The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992. 1993. Retina 23(6 Suppl):79–97

    PubMed  Google Scholar 

  13. Gass JDM, Hamed LM (1989) Acute macular neuroretinopathy and multiple evanescent white dot syndrome in the same patient. Arch Ophthalmol 107:189–193

    Article  CAS  PubMed  Google Scholar 

  14. Holz F, Kim RY, Schwartz SD, Harper CA, Wroblewski J, Arden GB, Bird AC (1994) Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye 8:77–83

    Article  PubMed  Google Scholar 

  15. Bryan RG, Freund KB, Yannuzzi LA, Spaide RF, Huang SJ, Costa DL (2002) Multiple evanescent white dot syndrome in patients with multifocal choroiditis. Retina 22:317–322

    Article  PubMed  Google Scholar 

  16. Kuznetcova T, Jeannin B, Herbort CP (2012) A case of overlapping choriocapillaritis syndromes: multimodal imaging appraisal. J Ophthalmic Vis Res 7:67–75

    PubMed Central  PubMed  Google Scholar 

  17. Bouchenaki N, Cimino L, Auer C, Tran VT, Herbort CP (2002) Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd 219:243–249

    Article  PubMed  Google Scholar 

  18. Slakter JS, Giovannini A, Yannuzzi LA, Scassellati- Sfarzolini B, Guyer DR, Sorenson JA, Spaide RF, Orlock D (1997) Indocyanine green videoangiography of multifocal choroiditis. Ophthalmology 104:1813–1819

    Article  CAS  PubMed  Google Scholar 

  19. Herbort CP, Mantovani A, Papadia M (2012) Use of indocyanine green angiography in uveitis. Int Ophthalmol Clin 52:13–31

    Article  PubMed  Google Scholar 

  20. Salzmann J, Lightman S (2000) The potential of newer immunomodulating drugs in the treatment of uveitis: a review. BioDrugs 13(6):397–408

    Article  CAS  PubMed  Google Scholar 

  21. Imrie FR, Dick AD (2007) Biologics in the treatment of uveitis. Curr Opin Ophthalmol 18(6):481–486

    Article  PubMed  Google Scholar 

  22. Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A (2011) Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Int Ophthalmol 31(2):165–173

    Article  PubMed  Google Scholar 

  23. Neri P, Eandi C, Arapi I, Posarelli C, Mariotti C, Giovannini A (2013) Long-term control of non-infectious paediatric panuveitis refractory to traditional immunesuppressive therapy, successfully treated with Adalimumab (HumiraTM). Clin Exp Rheumatol 31(3):458–462

    PubMed  Google Scholar 

  24. Larson T, Nussenblatt RB, Sen HN (2011) Emerging drugs for uveitis. Expert Opin Emerg Drugs 16(2):309–322

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS (2011) Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol 56(6):474–510

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piergiorgio Neri.

Additional information

Piergiorgio Neri and Federico Ricci have equally contributed to the study and they present the same rights to its intellectual properties.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neri, P., Ricci, F., Giovannini, A. et al. Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™). Int Ophthalmol 34, 359–364 (2014). https://doi.org/10.1007/s10792-013-9801-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-013-9801-z

Keywords

Navigation